R. Moges, Dimitri Desmonts de Lamache, G. Muench
Apr 1, 2017
Citations
0
Influential Citations
0
Citations
Journal
The FASEB Journal
Abstract
Mucosal inflammatory diseases cause great economic losses in the livestock industry. Previous research has shown that some macrolides effectively modulate bacterial‐induced inflammation in animal models. Tylvalosin (TYL) is a new macrolide antibiotic, meant to treat porcine respiratory diseases, in which inflammation is a major component of pathophysiology. The immune modulating effects of tylvalosin are unknown. We hypothesized that TYL may promote the resolution of inflammation in pigs, hence making it an appealing anti‐infective therapeutic.